1
|
Sharrak A, Aubrey J, Hua T, Wang S, Zambito G, Banks-Venegoni A. Negative workup? Laparoscopic cholecystectomy Still alleviates symptoms. Am J Surg 2024; 230:39-42. [PMID: 38052669 DOI: 10.1016/j.amjsurg.2023.11.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 11/07/2023] [Accepted: 11/27/2023] [Indexed: 12/07/2023]
Abstract
BACKGROUND Studies have shown that patients with abdominal pain and biliary dyskinesia (low ejection fraction <35 %) have significant improvement of symptoms following laparoscopic cholecystectomy, but there is lack of evidence that demonstrates whether patients with biliary symptoms and a normal ejection fraction (>35 %) will have similar results. METHODS Retrospective, single center study of patients with biliary pain and negative workup, including HIDA with EF>35 %, who were treated with laparoscopic cholecystectomy from 2017 to 2022. RESULTS There were 117 total patients. The mean age was 45.49 ± 15.5 years and 101 (86 %) were female. 101 (86 %) of patients underwent a right upper quadrant ultrasound, 91 had normal findings, 9 difficult to visualize anatomy and 1 had adenomyomatosis. All patients had a normal HIDA scan and ejection fraction 104 (89 %) of patients followed up in clinic within 30 days of surgical intervention. 87 (84 %) reported resolution of pre-operative symptomatology after surgical intervention. There was no statistically significant correlation between pain with CCK administration during HIDA (p = 0.803) scan or ejection fraction (p = 0.0977) with resolution of symptoms. CONCLUSIONS Laparoscopic cholecystectomy appears to be a beneficial intervention for patients with abdominal pain and normokinetic biliary disease. Offering surgical intervention early on can potentially save patients from exhaustive diagnostic investigations and possibly misdiagnosis.
Collapse
Affiliation(s)
- Aryana Sharrak
- Department of General Surgery, Corewell Health/Michigan State University, USA.
| | - Jason Aubrey
- Department of General Surgery, Corewell Health/Michigan State University, USA
| | - Tien Hua
- Michigan State University College of Human Medicine, USA
| | - Susanna Wang
- Michigan State University College of Human Medicine, USA
| | - Giuseppe Zambito
- Department of General Surgery, Corewell Health Blodgett Hospital, USA
| | | |
Collapse
|
2
|
Hashido N, Kobayashi M, Kawamoto A, Mabuchi S, Katsuda H, Ohtsuka K, Asahina Y, Hashimoto M, Okamoto R. Sphincter of Oddi dysfunction that could not be diagnosed with Rome IV: a case report. Clin J Gastroenterol 2023; 16:913-918. [PMID: 37615833 DOI: 10.1007/s12328-023-01848-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Accepted: 08/14/2023] [Indexed: 08/25/2023]
Abstract
A 30-year-old female patient presented with monthly episodes of severe intermittent upper abdominal pain, especially after consuming fatty meals. Over a period of 5 years, she visited the emergency department 21 times due to the intensity of the pain. Although the pain appeared consistent with biliary pain, both blood and imaging tests showed no abnormalities. Despite not meeting the Rome IV criteria, we suspected sphincter of Oddi dysfunction (SOD). To further investigate, we conducted hepatobiliary scintigraphy (HBS), which revealed a clear delay in bile excretion. With the patient's informed consent, we performed endoscopic sphincterotomy (EST) and as of 10 months later, there have been no recurrences. This case demonstrates an instance of SOD that could not be diagnosed using the Rome IV criteria alone but was successfully identified through HBS. It underscores the possibility of hidden cases of SOD among patients who regularly experience severe epigastric pain, where routine blood or imaging tests may not provide a diagnosis. HBS may be a useful non-invasive test in confirming the presence of previously undiagnosed SOD. As SOD can be easily treated with EST, updating the current diagnostic criteria to include such types of SOD should be considered in the future.
Collapse
Affiliation(s)
- Nanako Hashido
- Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), M&D Tower 14F, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
| | - Masanori Kobayashi
- Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), M&D Tower 14F, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
| | - Ami Kawamoto
- Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), M&D Tower 14F, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
| | - Suguru Mabuchi
- Department of General Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - Hiromune Katsuda
- Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), M&D Tower 14F, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
| | - Kazuo Ohtsuka
- Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), M&D Tower 14F, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
| | - Yasuhiro Asahina
- Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), M&D Tower 14F, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
| | - Masayoshi Hashimoto
- Department of General Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - Ryuichi Okamoto
- Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), M&D Tower 14F, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
| |
Collapse
|
3
|
Cherraqi A, Imrani K, Andour H, Messaoud O, Benelhosni K, Billah NM, Nassar I. Low phospholipids associated cholelithiasis syndrome in a young women: A rare case report. Radiol Case Rep 2022; 18:11-16. [PMID: 36324844 PMCID: PMC9619147 DOI: 10.1016/j.radcr.2022.09.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Revised: 09/18/2022] [Accepted: 09/21/2022] [Indexed: 11/07/2022] Open
Abstract
Low phospholipid-associated cholelithiasis (LPAC) is a rare, still poorly understood genetic disorder characterized by the association of an ABCB4 mutation and low biliary phospholipid concentration with recurrent cholelithiasis, responsible for the development of intrahepatic lithiasis in adults. The mutation of the ABCB4 gene, which codes for the ABCB4/MDR3 ductal protein, a biliary transporter, leads to precipitation of cholesterol crystals in the bile ducts leading to the formation of intrahepatic stones. The diagnosis should be suspected when at least 2 of the following criteria are present: onset of symptoms before age 40; recurrence of biliary symptoms (biliary colic, jaundice, cholangitis, acute pancreatitis) after cholecystectomy; presence of echogenic foci in the liver indicative of intrahepatic stones or biliary sludge; previous episode(s) of intrahepatic cholestasis during pregnancy; and a family history of gallstones in first degree relatives. Imaging techniques, especially ultrasound, play an important role in the detection of intrahepatic stones. The majority of clinical situations are simple and not serious, often managed by medical treatment with ursodeoxycholic acid, but certain complicated forms may require more invasive endoscopic or surgical treatment. We report a case of a 43-year-old woman, cholecystectomized 5 years ago, who presented with liver colic-like pain with cytolysis and biological cholestasis. Ultrasound and MRI showed the presence of intrahepatic calculi disseminated along the bile duct pathway creating a comet tail appearance and generating a posterior shadow cone. The interrogation of the patient showed that her sister was being followed for LPAC syndrome. The diagnosis of LPAC syndrome was retained and the patient was put under medical treatment with ursodeoxycholic acid with regular clinical, biological and radiological follow-up.
Collapse
|
4
|
Cotton PB, Suarez AL, Cunningham SC, Pauls Q, Bingener J, Morgan K. How much pain relief do patients expect after cholecystectomy? Surg Endosc 2018; 32:1867-70. [PMID: 29052062 DOI: 10.1007/s00464-017-5875-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2017] [Accepted: 09/04/2017] [Indexed: 11/27/2022]
Abstract
BACKGROUND Cholecystectomy is a common operation, increasingly performed, in the USA, for "functional gall bladder disorder" (FGBD). Outcomes of these surgeries are uncertain. In planning a study of FGBD, we needed to define the best outcome measures. METHODS We sought the opinions of patients (52 with FGBD and 100 with stones for comparison) coming to cholecystectomy. They were asked to respond in four ways about the minimum benefit they would count as "success." RESULTS We found that most patients do not expect cholecystectomy to relieve their pain-related disability completely, regardless of the presence or absence of stones. CONCLUSIONS Future studies of the success of surgery should use patient-centered outcome assessments, such as PGIC (patient's global impression of change), in addition to objective measures of the impact of treatment on key symptoms, such as pain.
Collapse
|
5
|
Sugawa C, Brown KL, Matsubara T, Bachusz R, Ono H, Chino A, Yamasaki T, Lucas CE. The role of endoscopic biliary sphincterotomy for the treatment of type 1 biliary dysfunction (papillary stenosis) with or without biliary stones. Am J Surg 2013; 207:65-9. [PMID: 24070665 DOI: 10.1016/j.amjsurg.2013.04.007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2012] [Revised: 12/31/2012] [Accepted: 04/24/2013] [Indexed: 01/26/2023]
Abstract
BACKGROUND This study assesses the safety and effectiveness of endoscopic biliary sphincterotomy (ES) in the treatment of papillary stenosis (PS) with and without biliary stones. METHODS The records of all patients who had endoscopic retrograde cholangiopancreatography (2,689 patients) from January 1, 1991, to August 1, 2010, were reviewed. There were 117 patients with PS who had ES. RESULTS All patients had biliary pain, a dilated common bile duct (CBD) with a maximum diameter of 10 to 25 mm, and elevated liver function tests. There were 46 patients who had prior cholecystectomy of whom 20 patients had CBD stones. The remaining 71 patients had no prior biliary surgery; there were no biliary stones in 14 patients. All patients were symptom free after ES with or without CBD stone retrieval. CONCLUSIONS ES is the optimal treatment for PS in patients with or without biliary stones. ES eliminates pain, corrects CBD dilation, and restores LFTs to normal.
Collapse
Affiliation(s)
- Choichi Sugawa
- Department of Surgery, Detroit Medical Center/Wayne State University, 4201 St Antoine, Suite 6C-UHC, Detroit, MI 48201, USA.
| | - Kristian L Brown
- Department of Surgery, Detroit Medical Center/Wayne State University, 4201 St Antoine, Suite 6C-UHC, Detroit, MI 48201, USA
| | - Toshiki Matsubara
- Department of Surgery, Detroit Medical Center/Wayne State University, 4201 St Antoine, Suite 6C-UHC, Detroit, MI 48201, USA; Matsubara Clinic, Ichinomiya, Aichi, Japan
| | - Rebecca Bachusz
- Department of Surgery, Detroit Medical Center/Wayne State University, 4201 St Antoine, Suite 6C-UHC, Detroit, MI 48201, USA
| | - Hiromi Ono
- Department of Surgery, Detroit Medical Center/Wayne State University, 4201 St Antoine, Suite 6C-UHC, Detroit, MI 48201, USA; Department of Internal Medicine, Seiwa Memorial Hospital, Sapporo, Japan
| | - Akiko Chino
- Department of Surgery, Detroit Medical Center/Wayne State University, 4201 St Antoine, Suite 6C-UHC, Detroit, MI 48201, USA; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Takuji Yamasaki
- Department of Surgery, Detroit Medical Center/Wayne State University, 4201 St Antoine, Suite 6C-UHC, Detroit, MI 48201, USA; Department of Endoscopy, Jikei University School of Medicine, Tokyo, Japan
| | - Charles E Lucas
- Department of Surgery, Detroit Medical Center/Wayne State University, 4201 St Antoine, Suite 6C-UHC, Detroit, MI 48201, USA
| |
Collapse
|